
Join us now for a live webinar on Monkeypox in PWH where @profchloeorkin and @MonicaGandhi9 discuss making treatment decisions and answer your most pressing questions. JOIN: https://t.co/SMSMnhhQhS #CE #CME #Monkeypox

CCO’s programs provide the latest clinically relevant, evidence-based education & support the competence of healthcare teams #HIV #HBV #HCV #COVIDー19 #IDTwitter

Join us now for a live webinar on Monkeypox in PWH where @profchloeorkin and @MonicaGandhi9 discuss making treatment decisions and answer your most pressing questions. JOIN: https://t.co/SMSMnhhQhS #CE #CME #Monkeypox

Excited to announce the newest addition to our Clinical Education Alliance. Rockpointe has joined our team to expand our primary care offerings and outreach to underserved communities. prn.to/3PA5sqR #primarycare #healthcareequity #communityhealthcare #CE #HCP #MedEd

Join us July 19 to have your most pressing #HDV questions answered! @CCO_InfDis @CCO_Hepatitis
Don't miss this live webinar on July 19th; have your questions about screening, diagnosis, and management of hepatitis delta virus (#HDV) answered by expert faculty. @Mariabutif @RobertGish REGISTER NOW➡️https://t.co/npMGkaxBqr #LiverTwitter #IDTwitter #TwitterRx #MedTwitter

Don't miss this live webinar on July 19th; have your questions about screening, diagnosis, and management of hepatitis delta virus (#HDV) answered by expert faculty. @Mariabutif @RobertGish REGISTER NOW➡️https://t.co/npMGkaxBqr #LiverTwitter #IDTwitter #TwitterRx #MedTwitter

STARTING SOON! Join Prof. Tarik Asselah today at 12:00 PM EDT as he provides rapid updates from #ILC2022 on: ✅Current #HBV management ✅#HCV treatment & implementation ✅Evolving #HDV data ✅HBV cure REGISTER NOW➡️https://t.co/bM2basZDFm #LiverTwitter #IDTwitter #TwitterRx

Don't miss this #podcast as Prof. Pietro Lampertico discusses how to identify which patients with chronic #HBV infection may not need immediate HBV treatment & the critical need to continue monitoring such patients even in the absence of ongoing therapy➡️https://t.co/fpkBIsAZs2

#POLL In your experience, what barriers to #HBV care do your patients experience in the clinical setting? Learn from Dr. Mindie Nguyen & Jennifer Wild as they discuss their experiences with barriers to HBV care & actions to reduce those barriers in 🇺🇸➡️https://t.co/mP6sssZOD4

STARTING SOON! Join Prof. Stefan Zeuzem today as he provides rapid updates on current #HBV management, #HCV treatment and implementation, evolving #HDV data, and HBV cure from #ILC2022. REGISTER NOW➡️https://t.co/5ZCc6fmU2O #LiverTwitter #IDTwitter #TwitterRx #MedTwitter

Don't miss this #webinar tomorrow, June 28th, as Prof. Stefan Zeuzem provides rapid updates on current #HBV management, #HCV treatment and implementation, evolving #HDV data, and HBV cure from #ILC2022. REGISTER NOW➡️https://t.co/jPgSQyrmno #LiverTwitter #IDTwitter #TwitterRx

Dr Michelle Collins-Ogle discusses key considerations for ART management for transgender PWH, including: ✅providing care within gender-affirmative care model ✅drug-drug interactions btw hormone therapy & ART ✅barriers to engagement & retention in care ➡️https://t.co/s5tFjyYI73

STILL TIME TO REGISTER! Join Prof. Tarik Asselah today as he provides rapid updates from #ILC2022 on: ✅Current #HBV management ✅#HCV treatment & implementation ✅Evolving #HDV data ✅HBV cure REGISTER NOW➡️https://t.co/yOFJLp1IB3 #LiverTwitter #IDTwitter #TwitterRx

In this case example presented by Dr. Milena Murray (@milenaPharmD), learn the latest data about maternal weight gain associated with ART use in pregnancy, including pregnancy effects and the role of baseline maternal weight➡️https://t.co/N2fI29rNM0 #HIV #IDTwitter #MedTwitter